Holen Sie sich die Stockscreener-App
14.01
1.89%
-0.27
Schlusskurs vom Vortag:
$14.28
Offen:
$14.29
24-Stunden-Volumen:
1.57M
Relative Volume:
0.43
Marktkapitalisierung:
$1.60B
Einnahmen:
$631.73M
Nettoeinkommen (Verlust:
$-239.78M
KGV:
-6.9356
EPS:
-2.02
Netto-Cashflow:
$-33.45M
1W Leistung:
-2.03%
1M Leistung:
+0.07%
6M Leistung:
+29.96%
1J Leistung:
-38.58%
1-Tages-Spanne:
$13.97
$14.43
1-Wochen-Bereich:
$13.80
$14.57
52-Wochen-Spanne:
$6.78
$24.76
10 X Genomics Inc Stock (TXG) Company Profile
Firmenname
10 X Genomics Inc
Sektor
Branche
Telefon
(925) 401-7300
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Vergleichen Sie TXG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
14.01 | 1.78B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
269.20 | 44.50B | 2.97B | 809.93M | 1.35B | 4.87 |
|
TEM
Tempus Ai Inc
|
75.86 | 12.80B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.94 | 12.81B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.33 | 7.63B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.88 | 6.67B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-22 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-05-01 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-10 | Eingeleitet | Barclays | Overweight |
| 2023-03-31 | Eingeleitet | Stephens | Overweight |
| 2023-02-02 | Eingeleitet | UBS | Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-08-18 | Herabstufung | Goldman | Neutral → Sell |
| 2022-07-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-07-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-10 | Eingeleitet | Stifel | Buy |
| 2020-03-05 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-10-07 | Eingeleitet | BofA/Merrill | Buy |
| 2019-10-07 | Eingeleitet | Cowen | Outperform |
| 2019-10-07 | Eingeleitet | JP Morgan | Overweight |
| 2019-09-24 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
10 X Genomics Inc Aktie (TXG) Neueste Nachrichten
Multi asset correlation models including 10x Genomics Inc.Rate Hike & Safe Capital Growth Trade Ideas - Newser
Is 10x Genomics Inc. still worth holding after the dipWeekly Volume Report & Technical Pattern Recognition Alerts - Newser
What are 10x Genomics Inc.’s technical support levelsQuarterly Portfolio Review & Stock Market Timing Techniques - sundaytimes.kr
What earnings revisions data tells us about 10x Genomics IncQuarterly Profit Review & Step-by-Step Swing Trade Plans - Newser
Is this a good reentry point in 10x Genomics IncMarket Growth Report & Safe Swing Trade Setups - Newser
Tools to monitor 10x Genomics Inc. recovery probabilityRecession Risk & Long-Term Safe Investment Plans - Newser
What technical models suggest about 10x Genomics Inc.’s comebackMarket Activity Recap & Weekly Sector Rotation Insights - Newser
Volume spikes in 10x Genomics Inc. stock – what they mean2025 Bull vs Bear & Growth-Oriented Investment Plans - Newser
What earnings revisions data tells us about 10x Genomics Inc.Market Risk Analysis & Risk Controlled Swing Alerts - Newser
Should you wait for a breakout in 10x Genomics Inc.Earnings Miss & Daily Entry Point Alerts - Newser
Is this a good reentry point in 10x Genomics Inc.Bear Alert & Safe Capital Growth Stock Tips - Newser
Applying big data sentiment scoring on 10x Genomics Inc.2025 EndofYear Setup & AI Enhanced Execution Alerts - Newser
How sentiment analysis helps forecast 10x Genomics Inc.Quarterly Risk Review & Low Risk High Reward Ideas - Newser
10x Genomics gets injunction against Parse Biosciences' ATAC Products - MSN
Technical signs of recovery in 10x Genomics Inc.July 2025 Levels & Smart Allocation Stock Tips - Newser
Is it time to cut losses on 10x Genomics Inc.2025 Sector Review & Weekly High Conviction Ideas - Newser
What MACD signals say about 10x Genomics Inc.Portfolio Update Summary & Daily Technical Stock Forecast Reports - Newser
Best data tools to analyze 10x Genomics Inc. stockWeekly Loss Report & Verified Momentum Stock Ideas - Newser
Multi asset correlation models including 10x Genomics IncJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - Newser
Analyzing drawdowns of 10x Genomics Inc. with statistical tools2025 Volatility Report & Risk Managed Investment Signals - Newser
Applying big data sentiment scoring on 10x Genomics IncQuarterly Performance Summary & Technical Buy Zone Confirmation - Newser
Trend analysis for 10x Genomics Inc. this week2025 Price Momentum & Low Drawdown Momentum Trade Ideas - Newser
What to do if you’re stuck in 10x Genomics Inc.Weekly Profit Report & Free Real-Time Volume Trigger Notifications - Newser
Chart based analysis of 10x Genomics Inc. trendsJuly 2025 Highlights & Free Long-Term Investment Growth Plans - Newser
How sentiment analysis helps forecast 10x Genomics IncPortfolio Value Report & Low Risk High Win Rate Stock Picks - Newser
Real time alert setup for 10x Genomics Inc. performanceTrade Entry Summary & Weekly High Momentum Picks - Newser
Will 10x Genomics Inc. Hold Gains Into Close getLinesFromResByArray error: size == 0 - thegnnews.com
Using portfolio simulators with 10x Genomics Inc. included2025 Fundamental Recap & Reliable Price Breakout Alerts - Newser
Finanzdaten der 10 X Genomics Inc-Aktie (TXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
10 X Genomics Inc-Aktie (TXG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Taich Adam | Chief Financial Officer |
Aug 22 '25 |
Sale |
13.79 |
22,315 |
307,657 |
309,273 |
| Hindson Benjamin J. | See Remarks |
Aug 22 '25 |
Sale |
13.79 |
7,486 |
103,209 |
440,888 |
2.73%
5.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):